Global CDMO Footprint Europe and North America presence enables end-to-end CDMO support from preclinical to commercial for small molecules, meeting multi-region development and manufacturing needs.

Regulatory Excellence Track Approved by top regulators including FDA, EMA, PMDA, KFDA, ANVISA and COFEPRIS, Uquifa offers proven quality and a pathway to faster, compliant submissions; a robust DMF portfolio (150+ filings, 26 COS) supports customers’ regulatory filings.

API and Filing Breadth A broad API catalog with extensive DMF activity provides ready-to-use components and regulatory scaffolding, reducing development risk and enabling smoother scale-up.

Market Presence & Events Active participation at Chemspec Europe 2025 and CPHI Americas 2025 demonstrates market expansion and creates direct sales opportunities with pharma and biotech customers seeking CDMO partnerships.

Growth & Partnership Potential Strategic growth history including India operations and acquisitions indicates capacity to scale, diversify supply, and form multi-regional partnerships for long-term CDMO collaborations.